(Q24244795)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15495023%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

0 references

1 reference

https://doi.org/10.1002/14651858.CD001960.pub4

1 reference

29 December 2023

title

Pharmacological interventions for non-ulcer dyspepsia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15495023%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15495023%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

S Soo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15495023%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

J Deeks

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15495023%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

B Delaney

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15495023%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

M Innes

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15495023%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

D Forman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15495023%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

18 October 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15495023%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

4 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15495023%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15495023%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

CD001960

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15495023%20AND%20SRC:MED&resulttype=core&format=json

Cimetidine in the treatment of non-ulcer dyspepsia: results of a randomized double-blind, placebo-controlled study

4 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

Chewable cimetidine versus chewable antacid in dyspepsia: which provides faster pain relief?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

Oral domperidone in chronic postprandial dyspepsia. A double-blind placebo-controlled evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

Long term acid suppressing treatment in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

Objective and subjective results of a randomized, double-blind, placebo-controlled trial using cisapride to treat gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Gastric and autonomic responses to stress in functional dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Cimetidine in the management of symptomatic patients with duodenitis: a double-blind controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Visceral perception in health and functional dyspepsia. Crossover study of gastric distension with placebo and domperidone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Effects of domperidone in patients with chronic unexplained upper gastrointestinal symptoms: a double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Cisapride stimulates antral motility and decreases biliary reflux in patients with severe dyspepsia.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Effect of cisapride on gastric emptying in dyspeptic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Open label study of long-term effectiveness of cisapride in patients with idiopathic gastroparesis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Symptom improvement from prokinetic therapy corresponds to improved quality of life in patients with severe dyspepsia.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Randomized, double-blind, placebo-controlled crossover trial of cimetidine and pirenzepine in nonulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Organic and functional disorders in 2000 gastroenterology outpatients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Do young patients with dyspepsia need investigation?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Cisapride in functional dyspepsia in general practice. A placebo-controlled, randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

The effect of a single rectal dose of cisapride on delayed gastric emptying

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

H2-receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a meta-analysis of randomized controlled clinical trials.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Dyspepsia in primary care: acid suppression as effective as prokinetic therapy. A randomized clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment. A multicentre 3-month follow-up study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Patients with functional dyspepsia responding to omeprazole have a characteristic gastro-oesophageal reflux pattern

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Bismuth subsalicylate in the treatment of gastritis due to Campylobacter pylori

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

A controlled trial of cimetidine for the treatment of nonulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Effects of long-term medical treatment with cimetidine and bethanechol in patients with esophagitis and Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Are routine duodenal and antral biopsies useful in the management of "functional" dyspepsia? A diagnostic and therapeutic study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Controlled clinical trial of treatment with cimetidine for non-ulcer dyspepsia.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Effect of treatment with cisapride alone or in combination with domperidone on gastric emptying and gastrointestinal symptoms in dyspeptic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Efficacy of cisapride therapy in functional dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Effect of cisapride on functional dyspepsia in patients with and without histological gastritis: a double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Endoscopic studies of dyspepsia in a general practice.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Measurement of gastric emptying in dyspeptic patients: effect of a new gastrokinetic agent (cisapride)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Non-ulcer dyspepsia and short term De-Nol therapy: a placebo controlled trial with particular reference to the role of Campylobacter pylori

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Campylobacter associated gastritis in patients with non-ulcer dyspepsia: a double blind placebo controlled trial with colloidal bismuth subcitrate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Dyspepsia in England and Scotland

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Effect of colloidal bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia. A double blind placebo controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis--effects of cisapride

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. The Frosch Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Studies of the epidemiology of peptic ulcer in a rural community: prevalence and natural history of dyspepsia and peptic ulcer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Domperidone in the Treatment of Dyspepsia: A Double-Blind Placebo-Controlled Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Double-blind evaluation of domperidone in acute vomiting and dyspeptic disorders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Pirenzepine in non-ulcer dyspepsia: a double-blind multicentre trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Cisapride in the long-term treatment of chronic gastroparesis: a 2-year open-label study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

The effect of cimetidine in non-ulcer dyspepsia. Experience with a multi-cross-over model

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Effect of cimetidine in patients with non-ulcer dyspepsia and erosive prepyloric changes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Non-ulcer dyspepsia in Nigerians clinical and therapeutic results.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Cisapride in non-ulcer dyspepsia. Results of a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Famotidine in the treatment of gastritis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Sucralfate in gastritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Cimetidine responders in non-ulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Campylobacter pylori and non-ulcer dyspepsia. 1. The final results of a double-blind multicentre trial for treatment with pirenzepine in Italy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Campylobacter pylori--a role in non-ulcer dyspepsia?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Gastric emptying and gastrointestinal symptoms in patients with atrophic gastritis and the effects of domperidone.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Controlled clinical trial with sucralfate in the treatment of macroscopic gastritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

The symptomatic effect of 1-day treatment periods with cimetidine in dyspepsia. Combined results from randomized, controlled, single-subject trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

The multi-crossover model for classifying patients as responders to a given treatment.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Helicobacter pyloriInfection and Non-Ulcer Dyspepsia: The Effect of Treatment with Colloidal Bismuth Subcitrate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Ranitidine for non-ulcer dyspepsia. A clinical study of the symptomatic effect of ranitidine and a classification and characterization of the responders to treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Wide gastric antrum in patients with non-ulcer dyspepsia. Effect of cisapride

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Efficacy of sucralfate in treatment of non-ulcer dyspepsia. A double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

A double-blind fluoroscopic study of cisapride on gastrointestinal motility in patients with functional dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Cisapride in functional dyspepsia: a double-blind, placebo-controlled randomized trial in general practice patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Cisapride in chronic dyspepsia: results of a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Dyspepsia and dyspepsia subgroups in Japan: symptom profiles and experience with cisapride

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Pathophysiology and treatment of functional dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Cisapride versus metoclopramide in the treatment of functional dyspepsia. A double-blind comparative trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Cisapride or cimetidine in the treatment of functional dyspepsia. Results of a double-blind, randomized, Swiss multicentre study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Distinct profiles of gastritis in dyspepsia subgroups. Their different clinical responses to gastritis healing after Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

A double-blind, randomized, placebo-controlled trial of cisapride in Saudi Arabs with functional dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

What are the real problems for patients with functional dyspepsia?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Gastric antral motility in functional dyspepsia. Effect of mental stress and cisapride.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Psychosocial factors and their role in symptomatic gastroesophageal reflux disease and functional dyspepsia.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

Ranitidine effectively relieves symptoms in a subset of patients with functional dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB2

7 January 2021

A survey of dyspepsia in Great Britain

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD001960.PUB2

Identifiers

DOI

10.1002/14651858.CD001960.PUB2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15495023%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference